Hui Ma
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 18
- Hepatitis C virus research 9
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Liver Diseases and Immunity 4
- Epidemiology 39
- Hepatitis B Virus Studies 20
- Liver Disease Diagnosis and Treatment 19
- Co-authors
- Xin Gao (34 shared papers)Huandong Lin (30 shared papers)Ming-Feng Xia (21 shared papers)Yu Hu (22 shared papers)Jian Gao (23 shared papers)Qiqige Aleteng (10 shared papers)Xiaoming Li (11 shared papers)Baishen Pan (12 shared papers)
- Journals
- PLoS ONE (6 papers)Journal of Gastroenterology and Hepatology (4 papers)Alimentary Pharmacology & Therapeutics (3 papers)Scientific Reports (3 papers)Hepatology International (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Hui Ma
122 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 125
- Hepatology 311
- Epidemiology 555
- Developmental Neuroscience 54
- Endocrinology, Diabetes and Metabolism 203
- Cancer Research 127
Countries citing papers authored by Hui Ma
This map shows the geographic impact of Hui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ma more than expected).
Fields of papers citing papers by Hui Ma
This network shows the impact of papers produced by Hui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ma. The network helps show where Hui Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 186 | |
| 2 | 2009 | 113 | |
| 3 | 2020 | 97 | |
| 4 | 2017 | 93 | |
| 5 | 2022 | 78 | |
| 6 | 2014 | 71 | |
| 7 | 2017 | 70 | |
| 8 | 2016 | 63 | |
| 9 | 2018 | 55 | |
| 10 | 2009 | 49 | |
| 11 | 2010 | 48 | |
| 12 | 2012 | 44 | |
| 13 | 2017 | 43 | |
| 14 | 2015 | 42 | |
| 15 | 2017 | 40 | |
| 16 | 2018 | 39 | |
| 17 | 2015 | 36 | |
| 18 | 2016 | 36 | |
| 19 | 2016 | 35 | |
| 20 | 2017 | 35 |
About Hui Ma
Hui Ma is a scholar working on Hepatology, Epidemiology, Cancer Research, Immunology and Molecular Biology, having authored 129 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (20 papers), Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (9 papers), Bone health and osteoporosis research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Vitamin D Research Studies (4 papers), Liver Diseases and Immunity (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Hepatology (311 citations), Epidemiology (555 citations), Developmental Neuroscience (54 citations), Endocrinology, Diabetes and Metabolism (203 citations) and Cancer Research (127 citations). Hui Ma has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Xin Gao, Huandong Lin, Ming-Feng Xia, Yu Hu, Jian Gao, Qiqige Aleteng, Xiaoming Li, Baishen Pan, Wanyuan He and Lai Wei. Their work appears in journals such as PLoS ONE, Journal of Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics, Scientific Reports and Hepatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.